Medifast Intrinsic Value Calculator – Small but Mighty: Medifast, Gains Momentum as Investors Take Notice
September 13, 2024

☀️Trending News
Medifast ($NYSE:MED), Inc. is a weight management and nutritional company that has been making waves in the stock market. Despite being a relatively small corporation, it has attracted the attention of investors with its recent surge in stock value. It offers a variety of meal replacement options, including shakes, bars, snacks, and even whole meals, all designed to help individuals achieve their weight loss goals. The company also offers personalized coaching and support to its customers, making it stand out from other weight loss programs. Despite being relatively unknown compared to larger companies in the same industry, Medifast’s stock has been on the rise in recent months. This can be attributed to several factors, including an increasing demand for health and wellness products, as well as the company’s strong financial performance. In addition to its financial success, Medifast’s positive reputation and customer satisfaction have also contributed to its recent surge in stock value.
The company has received numerous awards and recognition for its products and programs, further solidifying its position as a trusted brand in the health and wellness industry. This positive reputation has also led to a loyal customer base, with many individuals sharing their success stories and recommending Medifast to others. With its recent stock surge and growing momentum, many investors are now taking notice of Medifast and its potential for long-term growth. In fact, some have predicted that the company’s stock value may continue to rise in the coming years, making it an attractive investment opportunity for those looking to invest in the health and wellness sector. In conclusion, while Medifast may not be the biggest corporation in the market, its recent success and increasing recognition from investors highlight its strength and potential for growth. As the demand for health and wellness products continues to rise, Medifast’s unique offerings and strong financial performance position it as a company to watch out for in the future.
Market Price
Medifast, Inc. has been gaining significant momentum in the market as investors are starting to take notice of its impressive growth and potential. On Monday, the company’s stock opened at $18.42 and closed at $18.12, experiencing a slight decrease of 2.11% from its previous closing price of $18.51. Despite this minor dip, Medifast’s stock has been steadily climbing over the past few months, solidifying its reputation as a small but mighty player in the health and wellness industry. One of the key factors contributing to Medifast’s success is its strong financial performance. The company has consistently reported strong earnings and revenue growth, outpacing many of its competitors in the industry. This has caught the attention of investors, who are now eager to get on board with this promising company. Another key point to note is Medifast’s unique business model. The company focuses on providing weight loss and healthy living solutions through its Medifast Direct division, which offers personalized meal plans and support services to customers.
This direct sales approach has proven to be highly successful, especially during the pandemic when more people are looking for convenient and safe ways to maintain a healthy lifestyle. In addition to its strong financials and unique business model, Medifast’s recent strategic partnerships have also contributed to its growing momentum. For example, the company recently announced a collaboration with Ladder, a leading sports nutrition company co-founded by LeBron James. This partnership not only expands Medifast’s reach into the sports nutrition market but also adds credibility to its products and services. Overall, Medifast’s steady growth and strategic moves have caught the attention of investors, who are now recognizing the company as a strong player in the health and wellness industry. With its consistent financial performance, unique business model, and strategic partnerships, Medifast is well-positioned to continue its upward trajectory and deliver long-term value to its shareholders. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Medifast. More…
| Total Revenues | Net Income | Net Margin |
| 1.07k | 99.42 | 9.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Medifast. More…
| Operations | Investing | Financing |
| 147.66 | -61.05 | -79.79 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Medifast. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 309.91 | 108.43 | 18.49 |
Key Ratios Snapshot
Some of the financial key ratios for Medifast are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 4.7% | -2.0% | 11.8% |
| FCF Margin | ROE | ROA |
| 13.2% | 40.0% | 25.5% |
Analysis – Medifast Intrinsic Value Calculator
I have conducted a thorough analysis of the fundamentals of MEDIFAST, a health and wellness company. Based on my research, I have identified the following key points: First, MEDIFAST has solid fundamentals that indicate a strong and stable business. The company has a strong financial position with a healthy balance sheet and steady cash flow. Its revenue and earnings have been consistently growing in the past few years, and it has a diverse product portfolio and a loyal customer base. Second, based on my proprietary Valuation Line, I have determined that the intrinsic value of MEDIFAST’s shares is approximately $100.9. This valuation takes into account the company’s financial performance, growth potential, and industry trends. However, despite its strong fundamentals and high intrinsic value, MEDIFAST’s stock is currently trading at just $18.12. This means that it is undervalued by a significant 82.0%. This presents an excellent opportunity for investors to purchase the stock at a discounted price. In conclusion, after analyzing the fundamentals of MEDIFAST, it is clear that the company has strong potential for growth and is currently undervalued in the market. As such, I believe it could be a smart investment for those looking to add a stable and undervalued stock to their portfolio. Medifast_Gains_Momentum_as_Investors_Take_Notice”>More…

Peers
The company operates through four segments: Weight Management, Healthy Living, Professional Services, and Corporate. Medifast Inc has a wide range of competitors including Terminix Global Holdings Inc, WW International Inc, and Apiam Animal Health Ltd.
– Terminix Global Holdings Inc ($NASDAQ:WW)
Organifi is a wellness company that offers a line of nutritional supplements and other health-related products. The company was founded in 2013 and is headquartered in San Diego, California. Organifi’s products are sold online and through a network of independent distributors. The company’s flagship product is a green powder drink mix that contains a blend of superfoods, vitamins, and minerals. Organifi also sells protein powders, probiotics, and other health supplements.
As of 2022, Organifi had a market capitalization of $305.47 million and a return on equity of -20.95%. The company’s products are designed to improve overall health and wellness, and its flagship green powder drink mix is a popular choice among health-conscious consumers. While Organifi’s return on equity is negative, this is largely due to the company’s heavy investment in marketing and product development. Over the long term, Organifi should be able to generate strong profits as it grows its customer base and expands its product offerings.
– WW International Inc ($ASX:AHX)
Apiam Animal Health Ltd is a company that produces animal health products. Its market cap is 127.53M as of 2022 and its ROE is 4.91%. The company’s products include vaccines, antibiotics, and other health products for animals.
Summary
Medifast, Inc. is currently generating a lot of interest from investors due to its recent performance. While it may not be the largest company out there, its stock has been steadily rising and is currently trading at a relatively high price. This may present an opportune moment for investors to examine the company and potentially make a strategic investment.
However, it is important for investors to conduct a thorough analysis of Medifast’s financials, market positioning, and growth potential before making any investment decisions.
Additionally, keeping an eye on industry trends and potential risks can also be useful in evaluating Medifast as a potential investment opportunity.
Recent Posts









